Abstract. The capacity of human monocytoid cell lines and peripheral blood monocytes to modulate their expression of plasminogen receptors has been assessed. After PMA stimulation, THP-1 or U937 monocytoid cells were separated into adherent and nonadherent populations. Plasminogen bound to adherent cells with similar capacity and affinity as to nonstimulated cells. In contrast, the nonadherent cells bound plasminogen with 5-17-fold higher capacity (without a change in affinity). This increase was selective as urokinase bound with similar affinity and capacity to the adherent and nonadherent populations. Upregulation of plasminogen receptors on the nonadherent monocytoid cells was rapid, detectable within 30 min, and reversible, adhesion of the nonadherent cells resulted in a sixfold decrease in plasminogen binding within 90 min. The increase in plasminogen binding to the nonadherent cells was associated with a marked increase in their capacity to generate plasmin activity from cell-bound plasminogen.
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PMA stimulation of human peripheral blood monocytes increased their expression of plasminogen receptors by two-to fourfold. This increase was observed in both adherent and nonadherent monocytes. Freshly isolated monocytes maximally bound 5.0 x 1@ plasminogen molecules per cell, whereas monocytes cultured for 18 h or more maximally bound 1.7 × 107 molecules per cell, a 30-fold difference in receptor number. These results indicate that both monocytes and monocytoid cell lines can rapidly and markedly regulate their expression of plasminogen binding sites. As enhanced plasminogen binding is correlated with an increased capacity to generate plasmin, an enzyme with broad substrate recognition, modulation of plasminogen receptors may have profound functional consequences.
C
ELL-ASSOCIATED proteases participate in a wide variety of physiological and pathophysiologic processes. The enzymes of the fibrinolytic system, the plasminogen activators (urokinase [u-PA] 1 and tissue plasminogen activator [t-PA]), and plasmin, together represent one of the most broadly distributed and utilized of these protease systems. Plasmin is a serine protease with broad substrate recognition (49) . In addition to its role as the primary enzyme involved in dissolution of fibrin deposits, plasmin also degrades a number of matrix proteins (41) . This capability suggests that cell-associated plasmin also may play a key role in regulating cell migration.
Cell surface receptors for plasmin, its zymogen, plasminogen, and for the plasminogen activators provide a mechanism for cells to harness and regulate the activities of these proteases for performance of cellular functions. Cellular binding sites for plasminogen (36, 45) , plasmin (8) , u-PA (1, 6, 12, 57) , and t-PA (2, 3, 19) have been demonstrated on a variety of cells, and evidence for the regulation of specific cellular responses by these receptors is evolving. Plasmin(ogen) receptors are particularly widely distributed [reviewed in reference 36] and play a key role in regulating the activity of plasmin at cell surfaces.
Monocytes/macrophages exhibit a complex interrelationship with the fibrinolytic system. These cells can synthesize both u-PA (56) and t-PA (21, 22) as well as inhibitors of plasminogen activators (10) . The biosynthesis of these fibrinolytic components can be modulated by agonists (21, 22, 30, 58, 63) . In addition, monocytes and monocytoid cell lines express both u-PA and plasminogen receptors (35, 45, 57) . Direct evidence for the occupancy of plasminogen receptors on macrophages within inflammatory regions has been demonstrated recently (51) . In addition, monocytoid cells have the capacity to modulate their expression of u-PA receptors in response to agonists (14, 26, 29, 44, 52, and Lu et al. 1989 . Thromb. Haemostasis. 62:91). Thus, monocytoid cells possess numerous distinct mechanisms for regulating the proteolytic activity of the fibrinolytic system. In this study, we have investigated whether human monocytes and monocytoid cell lines can modulate their expression of plasminogen receptors. In view of the importance of the migratory functions of these cells in inflammatory processes and their overall capacity to regulate their fibrinolytic activities, the modulation of their plasminogen receptor function would be of central importance. Specific conditions are now identified which result in marked differences in plasminogen receptor expression, and these differences are associated with dramatic changes in the fibrinolytic activity of these cells.
Materials and Methods

Proteins
Glu-plasminogen was isolated from fresh plasma (prepared from blood drawn into 50 t~g/ml soybean trypsin inhibitor [Sigma Chemical Co., St. Louis, MO], 100 kallikrein inhibitor units/ml trasylol [FBA Pharmaceuticals, New York, NY], 3 mM benzamidine and 3 mM EDTA), by affinity chromatography on lysine-Sepharose (13) (Pharmacia Fine Chemicals, Piscataway, NJ) in the presence of 1 mM benzamidine, 0.02% NAN3, and 3 mM EDTA. The protein concentration was determined spectrophotometrically at 280 nm using an extinction coefficient of 16.8 (60) . Lys-plasminogen was purchased from National Institute for Biological Standards and Control (London, England). High-molecular weight two-chain urokinase (u-PA) was purchased from Calbiochem-Behring Corp. (La Jolla, CA). Gluplasminogen and u-PA were radiolabeled using a modified chloramine T method (45) . After labeling, u-PA was routinely repurified by affinity chromatography on benzamidine-Sepharose (24) and subsequently inactivated by treatment with 5 mM diisopropyl fluorophosphate for 30 min at 4°C. The labeled and unlabeled preparations of the ligands used in this study had the characteristics of previously described preparations from our laboratory (3Z 45).
Cells
The human monocytoid THP-1 cell line (55) was cultured in RPMI-1640 containing 100 U/ml penicillin G, 100/~g/ml streptomycin, 1 mM Na pyruvate, 0.05 M Hepes pH 7.35, 5 x 10-4% 2-mercaptoethanol, and 5% FCS (Mo-Medium). The human monocytoid cell line U937 and the human myeloid cell line HL60 were grown in RPMI-1640 containing 100 U/ml penicillin G, 100/~g/ml streptomycin and 5% FCS.
Human peripheral blood monocytes were prepared from blood drawn into 5 U/ml heparin, 10 mM theophylline, and 10 /~g/ml prostaglandin El~,. The blood was immediately centrifuged at 500 g for 10 min, and the platelet-rich plasma removed. After platelet depletion, two different protocols were used for monocyte isolation. Monocytes, isolated using an adhesion step, were prepared by centrifugation of the platelet-depleted blood cells, resuspended to the original blood volume in RPMI-1640, onto Ficoll-Hypaque (8% Ficoll [Sigma Chemical Co.], 10% Hypaque [Winthrop-Breon, New York, NY], d = 1.3570) to obtain the mononuclear cell fraction, and subsequent adherence of these cells (40-100 x 106 cells in 10-15 rnl RPMI-1640 medium) on fibronectin-gelatin dishes (5, 25) under sterile conditions. Fibronectin-gelatin dishes were prepared by incubation of 2% gelatin (type II; Sigma Chemical Co.) (10 ml/dish) for 1 h at 37°C, washing three times with Dulbecco's PBS (DPBS) and addition of autologous heparinized platelet-poor plasma (10 ml per dish). After 30 rain at 22°C and 1 h at 4°C, the plates were washed three times with DPBS and immediately used for adhesion of monocytes. After 1 h of adherence at 22°C, nonattached cells were removed by washing, and adherent monocytes were removed by incubation with 3.5 mM EDTA in DPBS for 10 rain at 4°C.
Isolation of monocytes without adhesion was performed using Sephracell-MN (Sephractec Co., Oklahoma City, OK) as described (59) . Briefly, Sephracell-MN was added to the platelet-depleted cell pellet at a ratio of 0.6:1 (vol/vol). After mixing by inversion, the suspension was centrifuged for 20 rain at 1,500 g. The mononuclear cell fraction was removed from the upper phase of the Sephracell-MN and washed once in PBS containing 0.1% BSA (Calbiochem-Behring Corp.) (PBS + BSA). Pellets of mononuclear cells were resuspended in PBS + BSA, mixed again with Sephracell-MN at a ratio of 1:2 (volume/volume), and centrifuged for 20 min at 1,500 g. After washing once in PBS + BSA, monocytes were suspended in Mo-medium.
Purity of the monocyte preparations was determined by microscopic examination of cells after Giemsa (Harleco, Gibbstown, N J) and esterase staining (15) . In addition, preparations were subjected to FACS analysis (see below) using an mAb against the Mac-1 alpha chain (MI/70) (kindly provided by Dr. D. Altieri from the Research Institute of Scripps Clinic, La Jolla, CA) (4). Only monocyte preparations containing <20% platelets (mean 13 + 4% in 6 experiments) and <10% lymphocytes were used in this study. (At a 20% contamination level, platelets would account for <1% of the 125I-plasminogen binding observed with a monocyte preparation). In addition monocyte preparations were routinely assayed for procoagulant activity (PCA) as an index for the absence of stimulation with LPS or other agonists (28) , and only preparations expressing <30 mU/106 cells were used.
Cell Stimulation and Adhesion
12-O-Tetradecanoylphorbol-13-acetate (PMA) (Sigma Chemical Co.), was routinely added at 40 nM to monocytoid cells and 4 nM to monocytes (monocytes were stimulated at a 10-fold lower concentration to minimize cytotoxicity). Unless indicated, stimulation was performed for 18 h in Momedium under sterile conditions. Viability was assessed by trypan blue exclusion and recovery by counting of cells in a hemocytometer. After PMA stimulation monocytoid cells become more adherent (54) and the proportion of adherent cells depends on the surface provided. At selected times, nonadherent cells were recovered by gentle decanting and the adherent cells by flushing with a pipette. Several types of vessels were used to obtain varying proportions of adherent and nonadherent cells. Using THP-1 cells, the following percent adherence was obtained after treatment with PMA (40 nM) for 18 h: 150-cm 2 flasks (Costar, Cambridge, MA), 60-75%; 100-ram dishes (Corning Glass Works, Coming, NY), 55-75 % (5-10 % without PMA stimulation); 30 ml Teflon bottles (Nalge Co., Rochester, NY), 15-25% (3-5% without PMA stimulation); gelatin-fibronectin dishes (85-95 %). Unless otherwise indicated, the 100-mrn Corning dishes were used in all experiments with the monocytoid cell lines.
Ligand Binding Analyses
Before use in binding analyses, the cells were washed three times in HBSS containing 1.2 mM CaCl2 and 1.6 mM MgSO4 (HBSS) and resuspended in HBSS containing 0.05 M Hepes, pH 7.35, and 0.1% BSA (HBSS-Hepes). Binding analyses were carried out in 1.5 ml polypropylene snap-cap tubes. Radiolabeled ligands, typically 100 nM 125I-plasminogen and 1 nM 1251-u-PA (final concentrations), unlabeled ligands, or buffer were added to a final volume of 200/zl. The cells were at 1.0 × 106 or 1.5 × 107 cells/ml in this 200-#1 volume for measuring plasminogen or u-PA binding, respectively. After incubation at 37°C for 1 h, triplicate 50-~1 samples were layered over 300 #1 20% sucrose in HBSS-Hepes and centrifuged for 2.5 rain in a Beckman microfuge (Beckman Instruments, Inc., Fullerton, CA). The tube tips were cut off and counted in a gamma counter. Molecules of ligand bound per cell were calculated based on the specific activity of each ligand. Specific binding was measured as the difference in the radioactivity bound to the cells in the presence and absence of a 40-100-fold final molar excess of nonlabeled ligand. Dissociation constants (Kd) were determined from specific binding isotherms using a nonlinear curve-fitting computer program, Ligand (42) . Linear correlation coefficients were calculated with a TI-55-II calculator (Texas Instruments Inc., Dallas, TX). Statistical comparisons were done using a paired comparison t test.
In some experiments, the cells were treated at low pH to remove potential endogenous ligands bound to receptors. The conditions under which >80% of t251-plasminogen or 125I-u-PA bound to the cells was dissociated were established for each cell type. These conditions were 10 min at pH 3.5 or pH 4.0 for the cell lines or monocytes, respectively. After this treatment the cell lines were >85-90% viable and monocytes were 65-70% viable. After such treatments, each cell type retained >90% of its capacity to bind added ~25I-plasminogen or ~25I-u-PA.
SDS-PAGE
Cell-bound ligands were extracted with 0.1% Triton-X-100 in 0.1 M Tris, pH 8.1, containing 10 mM EDTA, 1 mM PMSF, 100 U/ml trasylol. Extracts were boiled for 5 min and electrophoresed under reducing conditions on 8 % polyacrylamide slab gels in the buffer system of Laemmli (27) . Gels were stained with Coomassie blue, dried, and autoradiograms were developed with XRP-1 film (Eastman Kodak, Rochester, NY). The autoradiograms were scanned using a soft laser densitometer (Zeineh; Biomed Instruments Inc., Fullerton, CA). Molecular weights were estimated relative to protein standards obtained from Amersham Corp. (Arlington Heights, IL). Relative mobility (Rm) was calculated by dividing the distance from the top of the gel to the leading front of a protein band by the distance from the top of the gel to the dye front (61).
The Journal of Cell Biology, Volume 11 I, 1990 Ligand Dot Blots Cells (1.0 x 106) were lysed in 1 ml of 0.1% Triton-X-100 in 0.1 M Tris, pH 8.1, containing 10 mM EDTA, 1.0 mM PMSE 100 U/rnl trasylol. The extract, 20 #1, was applied to Immobilon-P filter paper (Millipore Co., Bedford, MA), using a dot-blot apparatus (Bethesda Research Laboratories, Gaithersburg, MD). After 90 min at 37°C, the filters were extensively washed with PBS containing 2 % BSA and incubated with 1251-plasminogen (100 nM) in the same buffer for 1 h at 37°C on a shaker. After washing with 2% BSA in PBS for 1 h with several changes, the filters were air dried and subjected to autoradiography.
Cell-associated Fibrinolytic Activity
Plasmin generation by isolated cell populations was determined after preincubating the cells (1.5 x 106/rnl in HBSS) with 15/xM Glu-plasminogen for 1 h at 37°C and washing the cells twice with HBSS. Plasmin generation was measured at 405 nm as a function of time after addition of u-PA (3 nM) and the chromogenic substrate S-2251 (0.5 mM) (Kabi Vitrum, Malta6, Sweden), in Tris HC1 pH 8.8, in a final volume of 200 tzl, using an ELISA plate reader (Molecular Devices, Palo Alto, CA).
FACS Analysis of Monocyte Preparations
Fluorescein-conjugated plasminogen (FITC-plasminogen) was prepared by conjugation of Glu-plasminogen with fluorescein (Sigma Chemical Co.) as described (16) . Conjugated fluorescein was separated from free fluorescein on Sephadex G-25 in PBS containing 0.1% NAN3. The fluorescein/protein ratio ranged from two to four (53) . To characterize the conjugate, its capacity to inhibit plasminogen binding to cells was assessed. 1251-plasminogen (0.1 ~M) binding to THP-1 cells was 80% inhibited by 2 pM unlabeled plasminogen and 74% inhibited by 2/~M FITC-plasminogen. For binding of FITC-plasminogen to monocytes and subsequent FACS analysis, ceils (1 x 107/ml) were incubated with FITC-plasminogen (10 ~M) in HBSS-Hepes containing 0.1% BSA for 1 h at 37°C. After washing once, the resuspended cells were analyzed by flow cytometry in a Becton Dickinson FACS IV/40 (Becton Dickinson Co., Oxnard, CA). Purity of the monocytes was assessed by incubation with a saturating concentration of MI/70 antibody followed by fluorescein-conjugated goat F(ab') 2 anti-mouse IgG (reactive with heavy and light chains) (Tago Corp., Burlingame, CA), and subsequent FACS analysis.
Results
Expression of Fibrinolytic Receptors on THP-1 Cells
The U937 cell line has been used extensively to study the fibrinolytic properties and the interactions of monocytoid cells with fibrinolytic molecules (30, 44, 45, 52, 57) . THP-1 cells exhibit a number of the characteristics of monocytes including ones not expressed by U937 cells (55) such as major histocompatibility class-II antigens (64) . Therefore, we sought to determine whether THP-1 cells could serve as a second model monocytoid cell line by studying the binding of the fibrinolytic ligands, plasminogen and u-PA, to the cells. In initial experiments, we found that both ~25I-plasminogen and 125I-u-PA bound to THP-1 cells in a time dependent manner. At 37°C, apparent equilibrium was achieved at 60 and 30 min for plasminogen and u-PA, respectively, typical of the time courses for binding of these ligands to monocytes, U937 cells, and many other cell types (36, 45) . Binding of both ligands was saturable. At a 100-nM input concentration of ~25I-plasminogen, binding was 83 % inhibited by a 40-fold molar excess of nonlabeled plasminogen (eight experiments). With t25I-u-PA at a 1 nM input concentration, binding was 86 % inhibited by a 50-fold molar excess of nonlabeled u-PA (six experiments). The reversibility ofplasminogen and u-PA to the THP-1 cells was assessed. Radiolabeled plasminogen (100 nM) or u-PA (1 nM) was incubated with the cells for 1 h at 37°C. At this time, a 90-fold excess of the homologous ter 10 and 30 min, respectively. The results are similar to the reversibility of the binding of these ligands to U937 cells reported by us (45) and others (51) . Representative Scatchard plots for the binding of plasminogen and u-PA to the THP-1 cells are shown in Fig. 1 . The data points from each Scatchard plot fit a straight line; the linear correlation coefficients for plasminogen and u-PA were r = -0.98 and -0.97, respectively. Scatchard analyses of the data from several experiments gave an average Kd of 1.8 + 0.5 #M and 2.4 + 3.0 × 107 plasminogen molecules maximally bound per cell (eight experiments). For u-PA, the Kd value was 1.3 + 1.0 nM and 7.6 5-2.7 × 1@ u-PA molecules were maximally bound per cell (six experiments). These values are very similar to those we have obtained for the binding of these two fibrinolytic ligands to U937 cells (45) .
Modulation of Plasminogen Receptors on Monocytoid Cells
Expression of u-PA receptors on U937 cells is increased by treatment with PMA, and this change has been reported to be more evident in the population of cells which become adherent after PMA stimulation (44, 52) . We sought to determine whether PMA, an agonist that exerts diverse effects on monocytes and monocytoid cells, could differentially modulate plasminogen receptor expression in the adherent and nonadherent populations of THP-I and U937 cells. THP-1 and U937 cells were cultured for 18 h in either the presence or absence of 40 nM PMA. The nonadherent and adherent cells were recovered separately, and ~:5I-plasminogen binding to the two populations of each cell type was measured.
At an input ligand concentration of 100 nM, marked differences in plasminogen binding to the two populations of cells were observed (Table I) . Whereas the adherent population of PMA-stimulated cells bound similar levels of plasminogen as the nonstimulated cells, binding to the nonadherent cells was greatly enhanced. The nonadherent THP-1 cells and U937 cells bound sixfotd more plasminogen compared to the adherent populations. Such differences were also observed with a third cell line that acquires macrophage characteristics upon PMA stimulation, the human promyeloid leukemic HL60 cell line. The nonadherent population of HL60 cells bound five times more ~25I-plasminogen than the adherent HL60 cells (Table I) . In contrast to these marked changes in plasminogen binding, u-PA binding was less dramatically altered. PMA stimulation increased u-PA binding by two-to threefold, and the adherent and nonadherent THP-1 and U937 cells showed no significant differences in binding (P > 0.05) based upon a paired comparison t-test. To determine whether the observed differences in plasminogen receptor expression reflected an altered affinity or capacity of the cells for the ligand, Scatchard analyses were performed with separated adherent and nonadherent populations of PMA-stimulated THP-1 and U937 cells. Straight lines were obtained suggesting that the differences were not due to induction of a second class of receptors with respect to affinity. The binding parameters summarized in Table II indicate that the affinity of plasminogen for the adherent and nonadherent PMA-stimulated cells and for the nonstimulated cells was very similar. The number of binding sites, however, increased markedly in the nonadherent cells. The difference between the adherent and nonadherent cells was 17-fold with the THP-1 cells and 5-fold with the U937 cells. To assure ourselves that such large differences in number of plasminogen binding sites on the adherent and nonadherent cells could be accurately quantitated in the assay configuration used, we measured the plasminogen binding at final nonstimulated THP-1 cell concentrations of 5.6 × 106/ml and 0.5 × 106/ml. This ll-fold difference in cell number approximates the difference in the plasminogen binding capacity of the adherent and nonadherent cells. At a 100 nM ~25I-plasminogen input concentration, 4.4 -J-0.4 × 105 and 3.0 + 1.19 × 105 plasminogen molecules were bound per cell (mean +SD of three experiments) at the higher and lower input concentration, respectively. As these differences are not statistically significant (P > 0.05), the 5-to 17-fold differences in the binding capacity of the nonadherent and adherent monocytoid cells appear to be appropriate estimates.
The changes in u-PA binding in these same cell populations were more modest and also arose from an increase in the number of binding sites and not from an increase in affinity. The differences in u-PA binding to the adherent and nonadherent populations of PMA-stimulated ceils were not statistically significant (P > 0.05), for either the U937 or the THP-1 cells. Stimulation of the two cell lines for up to 5 d with 120 nM PMA failed to induce greater changes in u-PA receptor expression. Acidification to remove any receptor associated endogenous u-PA did not enhance the capacity of the stimulated adherent or nonadherent cells to bind u-PA. The enhanced binding of plasminogen to the nonadherent cells was also demonstrable in ligand dot-blot analyses. Serial dilutions of detergent extracts of the same number of adherent and nonadherent PMA stimulated and nonstimulated THP-1 cells were applied to an Immobilon filter. After thorough washing, the filter was incubated with t2SI-plasminogen and then thoroughly washed again. An autoradiogram of the filter is shown in Fig. 2 . Reactivity with the t25I-plasminogen is clearly observed at higher dilutions of the nonadherent cells than of the adherent or the nonstimulated cells. All binding to the filter was abrogated (reviewed in reference 36) by 0.2 M 6-AHA (not shown), which prevents plasminogen binding to cells. Thus, this ligand dot-blot system provides a facile means to detect and compare the plasminogen binding capacity of cells and corroborates the increase in plasminogen binding to the nonadherent THP-1 cells.
Plasmin has been reported to bind to cells with a higher affinity than plasminogen (8) . To determine whether differential activation of plasminogen to plasmin could account for the differences in ligand binding, the ligands bound to the adherent and nonadherent ceils were analyzed on SDS-PAGE gels. Under reducing conditions, plasminogen (Mr = 92,000) can be distinguished from the plasmin heavy chain (Mr = 62,000). Autoradiograms of the gels were developed and then analyzed by densitometric scanning. At 1 h, the radiolabeled ligand incubated in the absence of cells was 93 % plasminogen and 7 % plasmin. The ligand bound to nonadherent and adherent cells as 83 and 81% plasminogen, respectively. Thus, the cells caused a moderate conversion of plasminogen to plasmin, but no difference in the amount of plasmin bound to the stimulated nonadherent and adherent cells was noted. Moreover, the extent of plasmin formation was similar in the bound and unbound ligand. This modest conversion of plasminogen to plasmin by the cells (10-12%) is in agreement with previous published data (19, 45, 51) and with other observations suggesting a similar affinity of plasminogen and plasmin for cells (20, 34, 39) . To exclude that the traces of plasmin generated by cells could give rise to the differences in plasminogen binding to the adherent and nonadherent monocytoid cells, THP-1 cells were stimulated with PMA (40 nM) for 90 min, and plasminogen binding to the nonadherent and adherent cells determined in the presence or absence of 100 U/ml trasylol. At a 100-nM input concentration of t25I-plasminogen, the nonadherent cells bound 6.3-and 5.3-fold more molecules of plasminogen per cell than the adherent cells, in the presence or absence of trasylol, respectively.
It also has been reported that Lys-plasminogen has a higher affinity for cells than native Glu-plasminogen (18, 38, Figure 3 . Molecular identity ofplasminogen bound to THP-1 cells. 125I-gluplasminogen (100 nM input concentration) was incubated with adherent and nonadherent PMA-stimulated THP-1 cells (1.5 × 106/ml) for 1 h at 37°C and the bound ligand was extracted using a 0.1% Triton solution as described in Materials and Methods. Cell bound material as well as ligand added (~25I-Gluplasminogen or ~25I-Lys-plasminogen) were analyzed by SDS-PAGE using 8% polyacrylamide gels under nonreducing conditions. In the autoradiogram shown, lane 1 is the added Glu-plasminogen; lane 2 is Lys-plasminogen; and lanes 3 and 4 are the ligands bound to the nonadherent and adherent cells, respectively. 
Felez eta|. Plasminogen Receptor Expression on Monocytes
Requirements for the Modulation of Plasminogen Receptor Expression on Monocytoid Cells
The relationship between PMA stimulation and cell adhesion in regulating plasminogen receptor expression in the monocytoid cells was examined. Nonstimulated THP-1 cells can adhere to fibronectin-gelatin; and this substratum was used to separate an adherent and a nonadherent population of nonstimulated as well as of PMA-stimulated cells. When ~25I-plasminogen binding was measured, the stimulated and nonstimulated adherent cells bound similar levels of the ligand (Table III) . In contrast, plasminogen binding to the two nonadherent cell populations differed markedly. The nonstimulated, nonadherent cells showed no significant difference in plasminogen binding compared with the adherent nonstimulated cells. The stimulated nonadherent cells, however, bound 14 times more plasminogen compared to the stimulated adherent population. Thus, stimulation of the cells was necessary for augmented plasminogen binding to the nonadherent cell population, u-PA binding increased slightly, but not significantly, in both the adherent and nonadherent populations of stimulated cells.
To determine the role of cell adhesion in plasminogen receptor modulation, THP-1 cells were stimulated with PMA in tissue culture flasks which allow only minimal cell adhesion. Under conditions where <0.1% of the cells were adherent after 18 h of stimulation with PMA, no increase in plasminogen binding to the cells was observed (2.8 + 1.2 and 3.1 + 0.8 x 105 molecules bound per cell for stimulated and nonstimulated cells respectively, at an input concentration of 100 nM ~:5I-plasminogen). This result suggests that an adherent population of cells is required for modulation of plasminogen receptor expression in the nonadherent cells, and this possibility was further assessed. THP-1 cells were stimulated with PMA in vessels with varying surface areas and adhesive properties such that the ratio of adherent to nonadherent cells differed. Plasminogen binding to the adherent and nonadherent populations was then measured. As shown in Fig. 4 , under conditions where <40 % of the cells were adherent, no difference in plasminogen binding to the adherent and nonadherent populations was detected. When the population of adherent cells exceeded 60%, the nonadherent cells exhibited more extensive binding of plasminogen compared to the adherent population. 2 Thus, to upregulate plasminogen receptor expression in the nonadherent cells, a significant proportion of the cells had to become adherent. These data also imply that the extent of surface available for adherence and not the presence of a distinct subpopulation of nonadherent cells is responsible for the separation of the two populations of cells and the modulation of receptor expression in the nonadherent cells. Corroboration of this point was obtained by exposing an isolated population of stimulated nonadherent cells to a second culture flask and again separating adherent and nonadherent populations (Table IV). The nonadherent cell population became 78 % adherent after 90 min in a new culture dish. Adherence induced downregulation of receptors in the previously nonadherent population and the new population of nonadherent cells bound eightfold more plasminogen molecules than the adherent cells. This eightfold difference was observed in either the presence or absence of PMA added during the second adherence.
2. As noted in Materials and Methods, some variation was observed in the distribution of adherent and nonadherent cells under similar experimental conditions. This difference in distribution could account for the variability in the increment in plasminogen binding to the nonadherent versus the adherent cells. In the experiments with THP-1 cells reported in the study, the ratio of plasminogen binding to the nonadherent versus the adherent cells ranged from 5.8 to 16.9, a 2.9-fold variation.
fy- Upregulation of plasminogen receptors in the nonadherent THP-I cells is a rapid phenomenon. In 30 min, the nonadherent cells bound 3.5-fold more plasminogen than the adherent cells (Fig. 5) . Maximal modulation of plasminogen receptors occurred in 90 min. At this time, 75-90% of cells were adherent and an eightfold increase in ~2~I-plasminogen binding to the nonadherent population was seen. An initial set of experiments was undertaken to determine if the adherent cells released soluble factors that induced plasminogen binding sites in the nonadherent cells. THP-1 cells were stimulated with 40 nM PMA in RPMI with or without 10% FCS, and the conditioned media derived after 1.5 or 18 h was added to nonstimulated THP-1 cells grown under conditions where adherence was prevented (in polypropylene tubes). ~25I-plasminogen binding was measured after culturing the cells in the conditioned media for either 1.5 or 3 h. These cells showed no increase in plasminogen binding relative to cells cultured in fresh media with or without FCS. For example, cells cultured for 3 h in the conditioned FCS or fresh media specifically bound 2.8 + 0.2 and 2.4 + 0.3 x l0 s molecules of ~25I-plasminogen per cell, respectively (100 nM ~2~I-plasminogen, 60 min incubation at 37°C).
Finally, we sought to determine whether PMA was unique among agonists in modulating plasminogen receptor expression (Table V) Several other agonists were also tested, but no modulation of plasminogen binding was observed (Table V) . These other agonists also failed to induce an adherent population of cells. Nevertheless, stimulation of the cells by the representative agonist, LPS, could be documented by increased expression of PCA of the cells. Thus, of the agonists tested, only the two that induced adherence influenced plasminogen receptor expression.
Functional Consequence of the Modulation of Plasminogen Receptors on Monocytoid Cells
We sought to determine if differences in plasminogen recep- tor expression were associated with changes in fibrinolytic activity of the cells. PMA-stimulated THP-1 cells were separated into adherent and nonadherent populations. These cells, as well as nonstimulated cells, were incubated with 15 /zM plasminogen for 60 min at 37°C, and then the cells were washed by centrifugation to remove unbound plasminogen. Plasmin generation was measured as a function of time upon addition of u-PA and the plasmin substrate, S-2251. As Time (mln) Figure 6 . Plasmin generation by THP-1 cells after PMA stimulation. Nonstimulated (zx) and the adherent (A) and nonadherent populations (e) of PMA-stimulated cells were incubated with 15 /zM plasminogen for 1 h at 37°C (in polypropylene tubes to prevent adherence). After washing, 3 nM u-PA was added to the system and plasmin generation measured as the hydrolysis of the chromogenic substrate S-2251 at 405 nm as described in Materials and Methods.
Table V. Effects of Monocyte Agonists on Plasminogen and Urokinase Receptor Expression
shown in Fig. 6 , the nonadherent cells were much more efficient in generating plasmin activity. After 60 min, eightfold more plasmin activity was generated by the nonadherent population of stimulated cells than by the nonstimulated cells. The adherent population of cells showed only a twofold increase in plasmin-generating activity.
Modulation of Plasminogen Receptor Expression in Monocytes
Experiments were undertaken to determine whether peripheral blood monocytes could also modulate their expression of plasminogen binding sites. In view of the influence of adherence on plasminogen receptor expression in cells of the monocytoid lineage, blood monocytes were isolated by an adherence-independent protocol using centrifugation of blood through Sephracell-MN (59). Monocytes were recovered by this method at high yield ("~2.8 × 107 cells from 200 ml of peripheral blood cells) and purity (>90%). The cells were cultured for 18 h in the presence or absence of 4 nM PMA and then separated into adherent and nonadherent populations. Binding isotherms were constructed at 37°C, and the Kd and number of plasminogen binding sites derived from Scatchard plots are summarized in Table VI . The affinities of all populations of monocytes were very similar and consistent with the value that we have previously reported for monocytes isolated using adherence to fibronectin-gelatin (35) . The number of plasminogen binding sites was altered by PMA stimulation. Both the adherent and the nonadherent populations of PMA stimulated cells had significantly (P < 0.02) higher plasminogen binding capacities than the nonstimulated cells; the extent of the increase was 2.5-to 4.4-fold. Differences in plasminogen binding to the adherent and nonadherent cells were not significantly different (P > 0.5) for either the stimulated or nonstimulated cells. When monocytes were maintained in suspension for the same time (18 h) in polypropylene tubes, PMA stimulation again induced a similar increase in plasminogen binding ( a population of adherent cells was not required for the upregulation of receptor expression in the stimulated cells. The limited yield of monocytes precluded detailed studies of u-PA binding to the same cell populations; however, a sufficient number of cells were obtained to permit evaluation of ~25I-u-PA binding at a single ligand dose. At this dose, 1 nM, no significant differences in u-PA binding was observed (Table VI). Neither stimulation nor adherence altered the extent of u-PA binding.
The above data indicate that monocytes are similar to the monocytoid cells with respect to showing a selective increase in plasminogen binding upon PMA stimulation. In contrast to the monocytoid cells, however, the expression of plasminogen binding sites was not different in the adherent and nonadherent populations of stimulated monocytes. In addition, the monocytes required a longer exposure to PMA to alter their plasminogen binding capacity. As noted in Fig.  5 , a marked increase in plasminogen binding to the monocytoid cells was observed within 30 min after exposure to PMA. With monocytes, a 6-h exposure to the stimulus was required to observe a statistically significant (P < 0.05) difference in plasminogen binding to the PMA stimulated versus nonstimulated cells (based on six experiments). The values for the plasminogen binding capacity of the nonstimulated monocytes are 30-80-fold higher than in our previous study (35) . In the present study, the monocytes were cultured for 18 h to allow time for PMA stimulation, whereas previously the studies were performed with freshly isolated monocytes. (28) . In parallel experiments, no difference in u-PA binding to the fresh and cultured monocytes was noted; at a 1 nM ~25I-u-PA input concentration, the fresh monocytes bound 2.0 + 0.5 × 104 molecules per cell compared to 3.5 +_ 1.2 x 104 molecules per cell (P > 0.5), (three experiments) in the cells cultured for 18 h. This dramatic difference in plasminogen binding to the fresh and cultured monocytes could also be observed by FACS analysis. Plasminogen was labeled with FITC and was shown to retain its capacity to bind to THP-1 cells. As shown in Fig. 7 , the fluorescence associated with the cultured monocytes was 1.5-2.0 orders of magnitude greater than with the same preparation of fresh cells. Addition of 0.15 M 6-AHA, reduced the fluorescence of both populations to the level in the absence of added FITC-plasminogen. The FACS analyses further indicate that the entire population of monocytes, rather than a subpopulation, increased its plasminogen binding capacity.
Discussion
In response to a variety of agonists, monocytes, and monocytoid cells undergo extensive phenotypic alterations including marked changes in their fibrinolytic properties (reviewed in reference 11). This study shows that plasminogen receptor expression can be dramatically altered in these cells, thus demonstrating an additional mechanism for the regulation of the fibrinolytic function of monocytoid cells. Indeed, increased receptor expression was associated with an enhanced capacity of the cells to generate plasmin, consistent with this functional consequence of plasminogen binding to cell surfaces (20, 34) . Changes in plasminogen receptor expression were noted with isolated peripheral blood monocytes and for the monocytoid cell lines tested although the conditions for attaining modulation may not be identical.
With the monocytoid ceils, stimulation and an adhesive event were both required to elicit the increase in plasminogen receptor expression. Agonists which stimulate monocytoid cells but do not alter their adhesive properties failed to change receptor expression; and, conversely, cell adhesion in the absence of a stimulus also failed to induce a change. Thus, PMA and vitamin D-3, which induced both adhesion and stimulation of monocytoid cells, were unique among the agonists tested in enhancing plasminogen receptor expression.
Other workers have previously reported the modulation of u-PA receptors on monocytoid cells by PMA or vitamin D-3 (14, 29, 44; Lu et al. 1989 . Thromb. Haemostasis. 61:91). Changes in the affinity of u-PA for its receptors on U937 cells stimulated with these agonists as well as on the increase in the number of u-PA receptors have been noted (14, 44, 52) . These changes were most pronounced after extended modulation of the cells with the agonists (4-5 d), suggesting that receptor modulation was associated with differentiation of the cells to a more macrophage-like phenotype. In our study, we were only able to detect modest changes in the number of u-PA receptors on the stimulated monocytoid ceils that we tested. Differences among U937 cell lines in various laboratories have been reported, including differences in their fibrinolytic functions (32), and these disparities could simply reflect differences in the ceils used or in the conditions of culture. From a broader perspective, our data clearly do show that plasminogen and u-PA binding sites can be independently modulated on ceils. Moreover, as regulation of plasminogen receptor expression is a very rapid event, differentiation of the monocytoid cells to a more macrophage-like phenotype does not appear to be required for these changes to occur.
The role of cell adhesion in induction of plasminogen binding sites is complicated. The possibility that adhesion prevents the upregulation of plasminogen receptors induced by stimulation seems unlikely since the development of a population of adherent cells was required to see the increase in plasminogen binding to the nonadherent cells. As the number of adherent and nonadherent cells was determined by the available surface and the nonadherent populations could rapidly downregulate receptor expression upon adherence, the differential binding of plasminogen to clonally distinct subpopulations of cells can be excluded also. A plausible explanation for these observations is that the adherent cells release components that influence the plasminogen binding properties of the nonadherent but not the adherent cells. Proteolysis of cells has been recently shown to markedly augment their ability to bind plasmin (9). The reversibility of plasminogen receptor expression argues against a role of released proteases from the adherent cells in the process. The communication between the adherent and nonadherent cells is rapid and must induce major changes in the cell-surface properties to account for the magnitude of the increase in receptor number. Cell adhesion is, in fact, known to induce rapid changes in the properties of monocytoid cells. For example, changes in oncogene expression are initiated within 30 min after cell adhesion (23) . We have provided initial evidence for a role of both proteinaceous and nonproteinaceous (gangliosides) cell surface molecules as plasminogen binding sites on cells (40) . In view of the magnitude of the increase in plasminogen binding observed, a major alteration in the cell-surface properties of the nonadherent cells, rather than a change in the density of a single protein receptor, seems most likely. From a biological perspective, our data suggest that the monocyte can upregulate its number of plasminogen receptors in a very short period of time. Associated with this increase in receptor number is an increase in the capacity of the cells to generate plasmin. Plasmin on the cell surface may perform a variety of functions including degradation of substratum. This would permit the cells to migrate in a directed fashion. After migration, adhesion to a new surface would be associated with a rapid downregulation of plasminogen receptor expression, and the cell:substratum contacts would become stabilized. This scenario could be of particular importance in inflammatory reactions and for cell invasion such as during tumor cell metastasis.
